Frazier Life Sciences Management »

Aerovate Therapeutics shares owned by Frazier Life Sciences Management

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Frazier Life Sciences Management from 13F filings

Historical chart of Frazier Life Sciences Management investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Frazier Life Sciences Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Frazier Life Sciences Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $27M 1.2M 22.63
2023-09-30 $16M 1.2M 13.57
2023-06-30 $17M 995k 17.15
2023-03-31 $6.8M 338k 20.17